Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,300 | 3 | 92.1% |
| Food and Beverage | $543.79 | 12 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $6,735 | 8 | $0 (2018) |
| PFIZER INC. | $52.77 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $20.52 | 1 | $0 (2019) |
| AbbVie Inc. | $12.50 | 1 | $0 (2021) |
| Vapotherm Inc | $11.61 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $11.20 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $24.11 | 2 | AbbVie Inc. ($12.50) |
| 2020 | $11.20 | 1 | Merck Sharp & Dohme Corporation ($11.20) |
| 2019 | $20.52 | 1 | E.R. Squibb & Sons, L.L.C. ($20.52) |
| 2018 | $6,772 | 10 | La Jolla Pharmaceutical Company ($6,735) |
| 2017 | $15.85 | 1 | PFIZER INC. ($15.85) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2021 | Vapotherm Inc | VAPOTHERM (Device) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/12/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/08/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.52 | General |
| Category: Cardiovascular | ||||||
| 10/18/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/06/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: GIAPREZA | ||||||
| 09/06/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $124.71 | General |
| Category: GIAPREZA | ||||||
| 08/09/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: GIAPREZA | ||||||
| 08/09/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $124.83 | General |
| Category: GIAPREZA | ||||||
| 08/02/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $52.29 | General |
| Category: GIAPREZA | ||||||
| 08/02/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: GIAPREZA | ||||||
| 07/26/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: GIAPREZA | ||||||
| 07/26/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $119.36 | General |
| Category: GIAPREZA | ||||||
| 05/18/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/03/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 369 | 677 | $139,577 | $48,192 |
| 2022 | 6 | 312 | 418 | $134,686 | $41,937 |
| 2021 | 6 | 520 | 989 | $195,649 | $65,997 |
| 2020 | 8 | 530 | 934 | $182,014 | $60,218 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 166 | 464 | $74,704 | $27,690 | 37.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 107 | 111 | $26,307 | $9,438 | 35.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 71 | 73 | $32,777 | $8,848 | 27.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 16 | $3,696 | $1,411 | 38.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $2,093 | $805.61 | 38.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 186 | 187 | $83,963 | $26,852 | 32.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 139 | $22,379 | $7,114 | 31.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 34 | 35 | $8,295 | $2,268 | 27.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 31 | $7,130 | $2,010 | 28.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $6,165 | $1,915 | 31.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 11 | $6,754 | $1,778 | 26.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 214 | 642 | $103,362 | $35,202 | 34.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 67 | 67 | $29,945 | $9,660 | 32.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 117 | 118 | $27,966 | $9,624 | 34.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 79 | 119 | $27,447 | $9,170 | 33.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 22 | 22 | $3,548 | $1,213 | 34.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 21 | 21 | $3,381 | $1,127 | 33.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 153 | 417 | $64,358 | $21,867 | 34.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 93 | 197 | $44,818 | $14,425 | 32.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 105 | 106 | $25,069 | $8,225 | 32.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 54 | 54 | $21,762 | $7,841 | 36.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 31 | 31 | $8,990 | $2,754 | 30.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 40 | 40 | $6,500 | $2,061 | 31.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 32 | 67 | $6,734 | $1,951 | 29.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 22 | 22 | $3,784 | $1,094 | 28.9% |
About Dr. Kelly Coon, M.D
Dr. Kelly Coon, M.D is a Internal Medicine healthcare provider based in Scottsbluff, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003864703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kelly Coon, M.D has received a total of $6,844 in payments from pharmaceutical and medical device companies, with $24.11 received in 2021. These payments were reported across 15 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,300).
As a Medicare-enrolled provider, Coon has provided services to 1,731 Medicare beneficiaries, totaling 3,018 services with total Medicare billing of $216,344. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Scottsbluff, NE
- Active Since 05/04/2006
- Last Updated 06/12/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003864703
Products in Payments
- GIAPREZA (Drug) $6,735
- CHANTIX (Drug) $52.77
- ELIQUIS (Drug) $20.52
- DALVANCE (Drug) $12.50
- VAPOTHERM (Device) $11.61
- ZERBAXA (Drug) $11.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Scottsbluff
Mohammed Salhab, Md, MD
Internal Medicine — Payments: $7,031
Dr. Eric Wiebe, M.d, M.D
Internal Medicine — Payments: $1,380
Dr. Brittany Eirich, Md, MD
Internal Medicine — Payments: $325.15
Dr. Serozan Amroliwalla, M.d, M.D
Internal Medicine — Payments: $292.53
Dr. Armando Magana, M.d, M.D
Internal Medicine — Payments: $273.60
Thao Nguyen, Do, DO
Internal Medicine — Payments: $255.26